anti-obesity medicine
Scope
Date
~
-
Bio & Pharma
Celltrion teams up with bio venture to develop new anti-cancer drug
South Korea's biopharmaceutical company Celltrion Inc. will develop an anti-cancer drug that combines oncolytic virus technology with biosimilars un...
Feb 28, 2023 (Gmt+09:00)
-
Bio & Pharma
SillaJen starts US trial of anti-cancer drug from Basilea
SillaJen Inc. said on Monday it has enrolled the first patient in a US phase 1 trial of an anti-cancer drug BAL0891 licensed from Swiss drugmaker Ba...
Feb 27, 2023 (Gmt+09:00)
-
Bio & Pharma
Novel medicines poised to be Korea’s next mainstay export
South Korea, a major global generic and biosimilar medicine producer with leading names such as Samsung Biologics Co. and Celltrion Inc., has rapidl...
Feb 27, 2023 (Gmt+09:00)
-
Bio & Pharma
Korea United Pharm signs contract to supply medicines to Saudi Arabia
Korea United Pharm. Inc. announced on Monday that it signed a contract to supply nine types of medicines, including 11 anticancer drugs, to Saudi ph...
Feb 20, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma, Sanofi to jointly market Plavix
GC Biopharma Co. (formerly Green Cross Corp.) said on Monday it has entered into a joint sales partnership with Sanofi-Aventis Korea, the South Kore...
Feb 13, 2023 (Gmt+09:00)
-
Aerospace & Defense
LIG Nex1 to work with Romanian state-run defense supplier
South Korea's defense contractor LIG Nex1 Co. will join hands with ROMARM, a Romanian state-run defense company, to develop anti-aircraft missiles a...
Feb 09, 2023 (Gmt+09:00)
-
IPOs
S.Korea's InnoGene sets its public offering price at 3,000 won
InnoGene, which is seeking to be listed on the Kosdaq market at the end of this month, said on Wednesday that it has confirmed its offering price at...
Feb 09, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Boryung receives EU GMP certification
South Korean pharmaceutical company Boryung announced that its production facility for anti-cancer injections in Yesan, South Chungcheong Province, ...
Feb 06, 2023 (Gmt+09:00)
-
Aerospace & Defense
S.Korea's top sci-tech school creates cutting-edge anti-drone technology
A research team at South Korea's top science and technology university has developed an anti-drone technology that can remotely neutralize a city-in...
Feb 01, 2023 (Gmt+09:00)
-
Bio & Pharma
Ybrain, Chong Kun Dang join forces for digital medicine distribution
South Korean electroceutical platform company Ybrain Inc. said on Tuesday it has entered into a joint promotion agreement with Chong Kun Dang Pharma...
Jan 31, 2023 (Gmt+09:00)
-
Bio & Pharma
Bridge Biotherapeutics, Pinotbio develop lung cancer treatment
South Korea's biotech companies Bridge Biotherapeutics Inc. and Pinotbio on Thursday said they will jointly develop new antibody-drug conjugates (AD...
Jan 27, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare launches anti-cancer biosimilar Vegzelma in Japan
Celltrion Healthcare Co. Ltd. said on Thursday that it launched Vegzelma, a biosimilar to the anti-cancer drug Avastin (active ingredient: bevacizum...
Jan 26, 2023 (Gmt+09:00)
-
Bio & Pharma
LG Chem completes acquisition of US biotech firm AVEO
LG Chem Ltd. is set to complete its $571 million purchase of the US biotech firm AVEO Pharmaceuticals Inc. on Friday, which would strengthen its ant...
Jan 19, 2023 (Gmt+09:00)
-
Bio & Pharma
MedPacto's anti-cancer substance designated as US FDA fast-track item
South Korean biotech company MedPacto Inc. ’s Vactosertib monotherapy for osteosarcoma patients has been designated as a fast-track developmen...
Jan 18, 2023 (Gmt+09:00)
-
Steel
Korean steelmakers accuse Japanese rivals of product dumping
As Japanese hot-rolled steel plates have flooded into South Korea at even lower prices than those from China, Korean steel manufacturers are consi...
Jan 10, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's CMG Pharmaceutical opens animal medicine unit
CMG Pharmaceutical, a subsidiary of South Korea's CHA Biotech, on Monday announced the launch of an animal medicine unit and entry into the market f...
Dec 20, 2022 (Gmt+09:00)
-
Korean startups
AI medical startup Arpi wins Pre D.Day X SNU Medicine event
South Korean startup accelerator D.Camp hosted this year’s last demo day on Saturday in collaboration with Seoul National University’s C...
Dec 18, 2022 (Gmt+09:00)
-
Chemical Industry
S.Korea rules dumping of polyamide film by China, Thailand, Indonesia
The South Korean government has issued a ruling on the dumping of polyamide film from China, Thailand and Indonesia and aluminum hydroxide from Chin...
Dec 16, 2022 (Gmt+09:00)
-
Bio & Pharma
S. Korea's SillaJen launches clinical trials in US for new anti-cancer drug
South Korean biotech company Sillajen Inc. has started recruiting patients for Phase 1 clinical trials in the US for an anti-cancer drug from a Swis...
Dec 14, 2022 (Gmt+09:00)
-
Artificial intelligence
LG Group think tank unveils breakthrough AI tech Exaone
LG AI Research, the artificial intelligence (AI) think tank of South Korea's LG Group, on Thursday unveiled Exaone, a gigantic AI technology that ra...
Dec 09, 2022 (Gmt+09:00)
-
Aerospace & Defense
Korea LIG Nex1 to enjoy record earnings on missile exports
LIG Nex1 Co., a leading South Korean defense company, is expected to see record earnings this year on strong missile exports, helping its shares sur...
Nov 18, 2022 (Gmt+09:00)
-
Bio & Pharma
Hanmi’s anti-cancer drug Rolontis gets FDA approval; US sale via Spectrum
South Korea’s Hanmi Pharmaceutical Co. said on Tuesday that Rolontis, an anti-cancer drug it has jointly developed with its US partner, has ob...
Sep 13, 2022 (Gmt+09:00)
-
Earnings
Celltrion logs strong Q2 earnings powered by biosimilars
South Korea’s biopharmaceutical maker Celltrion Inc. on Friday reported strong quarterly earnings thanks to healthy demand for its biosimilar ...
Aug 05, 2022 (Gmt+09:00)
-
Pre-IPOs
Lemon Healthcare aims for IPO and triple jump in revenue
Imagine making a doctor’s appointment with a click of a button on a smartphone app. Once at the clinic or hospital, the app will guide the use...
Jun 02, 2022 (Gmt+09:00)
-
Bio & Pharma
Korean drugmakers close to commercializing COVID-19 vaccine, pill
South Korea’s biopharmaceutical companies are close to commercializing a COVID-19 vaccine and treatment pill as they are on the brink of compl...
Apr 25, 2022 (Gmt+09:00)
-
Aerospace & Defense
LIG Nex1 anti-tank missile in spotlight amid Ukraine war
An anti-tank guided weapon produced by South Korean defense exporter LIG Nex1 Co. is in the spotlight as Ukraine said its forces destroyed Russian a...
Apr 15, 2022 (Gmt+09:00)
-
Bio & Pharma
Korea Hanmi to launch blockbuster hypertension drug in China
South Korea’s Hanmi Pharmaceutical Co. is set to launch its blockbuster high blood pressure drug Amosartan in China, the world’s largest...
Mar 11, 2022 (Gmt+09:00)
language -
Tech, Media & Telecom
S.Korea fines Google $180 mn for operating system market abuse
South Korea's Fair Trade Commission (FTC) on Tuesday imposed a fine of 207.4 billion won ($180 million) on Google, alongside a correction order, aft...
Sep 14, 2021 (Gmt+09:00)
-
Covid-19 treatment
Indonesia grants emergency use approval for Celltrion’s COVID-19 treatment
South Korean drugmaker Celltrion Inc. has received the Indonesian government’s permission for restricted use of its COVID-19 treatment Regkiro...
Jul 20, 2021 (Gmt+09:00)
-
IPOs
HK inno.N poised to bolster S.Korea's IPO lineup in H2
HK inno.N Corp., a pharmaceuticals unit of South Korea's Kolmar Korea, is set to go public in early August at a valuation of around 2 trillion won (...
Jun 29, 2021 (Gmt+09:00)